HomeProdukt-ListeSchlüsselintermediate.CAS: 870281-82-6 CAL-101 iDelalisib GS-1101 PULVER

CAS: 870281-82-6 CAL-101 iDelalisib GS-1101 PULVER

$10 - 20 /Gram
10 /Gram (Minimum der Bestellmenge)
Zahlungsart:
T/T,Paypal
Incoterm:
FOB
Minimum der Bestellmenge:
10 Gram
Transport:
Land,Air,Express,Ocean
Hafen:
Shanghai,Shenzhen,Guangzhou
  • Produktbeschreibung
Overview
Produkteigenschaften

ModellIdelalisib

MarkeRhein

GradePhamaceutical Grade

Place Of OriginChina

Test MethodHPLC UV COA

Specification10g:vial/bag

PackageBottles, foil bags

TrademarkRHINE

Sec-HPLC99.5%

Molecular FormulaC22H18FN7O

MW415.4

Cas870281-82-6

Lieferfähigkeit & Zusatzinformationen

VerpakungFolienbeutel / Flasche

Produktivität500 grams per month

TransportLand,Air,Express,Ocean

Ort Von ZukunftChina

Unterstützung über500grams/month

Zertifikate N/A

HS-Code2934993000

HafenShanghai,Shenzhen,Guangzhou

ZahlungsartT/T,Paypal

IncotermFOB

Verpackung & Lieferung
Verkaufseinheiten:
Gram
Pakettyp:
Folienbeutel / Flasche
CAS NO: 870281-82-6 Molecular Formula: C22H18FN7O Molecular Weight: 415.42 Purity: 98% Haltbarkeit 2 Jahre Storage: 2~8°C In 2012, "RHINE" reported on a new experimental drug that it said could not only prolong the survival of patients with incurable leukemia, but also without the need for traditional chemotherapy. The drug in the report is Adelaris, and the production of this drug means that great progress has been made in the treatment of CLL. Undoubtedly, this is a great boon for...

Produktgruppe : Schlüsselintermediate.

Mail an Lieferanten
  • *Fach:
  • *Zu:
    Ms. Caroline
  • *E-Mail-Adresse:
  • *Nachrichten:
    Ihre Nachrichten muss zwischen 20-8000 Zeichen sein
Anfrage versenden
*
*

HomeProdukt-ListeSchlüsselintermediate.CAS: 870281-82-6 CAL-101 iDelalisib GS-1101 PULVER

Zuhause

Product

Phone

Über uns

Anfrage

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

senden